Christina T. Loguidice

In the largest study to date, ginger in combination with a 5-HT3 receptor antagonist antiemetic was found to significantly reduce CINV in patients with cancer.

While the concept of shrinking humans is quite fantastic and unrealistic, scientists have already developed tiny vessels that can hunt down diseased cells and deliver precise drug doses.

Patients with cancer who experience moderate to severe pain may be prescribed opioids and could become addicted to them; thus, it is important for oncology nurses to understand addiction and how to assess and manage pain in this patient population.

Peritoneal carcinomatosis is the metastatic spread of cancer within the peritoneal cavity by seeding from a primary malignancy, such as colon, ovarian, gastric, or breast cancer; it may also occur as a primary disease, as in the case of peritoneal mesothelioma.

Marilyn Haas, PhD, RN, Mountain Radiation Oncology, Asheville, North Carolina, and Stephen Hahn, MD, University of Pennsylvania, Philadelpia, introduced the audience to several relatively new types of sophisticated machinery that allow radiation to be distributed more accurately, resulting in less toxicity to surrounding tissue.

As you can well imagine, a cancer diagnosis can lead to an incredible amount of distress, which may be amplified once a patient starts to undergo treatment and experience its related side effects.

Jonathan Kaufman, MD, Emory University School of Medicine, provided an overview of this plasma cell cancer and discussed some of the novel therapeutics that have considerably improved survival.

Geralyn Lucas, a very spunky breast cancer survivor, gave an amazing key note address that kept the audience engaged with her humor.

Eating nutritiously is vital for all individuals, as it can reduce the risk of cancer and other debilitating diseases.

Twitter really only wants to know one thing: "What are you doing?"

As exotic international locales become more accessible and American palates acquire a taste for more unusual fare, physicians may find themselves treating patients infected with organisms that are rarely seen in the United States, such as Anisakis spp.

Updates to the NCCN Prostate Cancer Guidelines were presented by James L. Mohler, MD.